FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 195 filers reported holding FIBROGEN INC in Q3 2018. The put-call ratio across all filers is 5.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $27,586 | -99.6% | 1,722 | -99.4% | 0.00% | -98.3% |
Q2 2021 | $7,858,000 | +1234.1% | 295,086 | +2944.6% | 0.06% | +90.3% |
Q3 2018 | $589,000 | -51.4% | 9,692 | -50.0% | 0.03% | -69.3% |
Q2 2018 | $1,213,000 | +145.5% | 19,383 | +81.4% | 0.10% | +55.4% |
Q1 2018 | $494,000 | -12.1% | 10,683 | -9.8% | 0.06% | -18.8% |
Q4 2017 | $562,000 | – | 11,850 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |